Market Forecast by Countries (Germany, United Kingdom, France, Italy, Russia, Spain, Rest of Europe), By Technology (Molecular Assay Technologies, Non-molecular Assay Technologies), By Product & Service (Reagents & Consumables, Instruments, Software & Services), By Application (Diagnostic Applications, Research Applications), By End-User (Independent Reference Laboratories, Hospitals & Transplant Centers, Research Laboratories & Academic Institutes) And Competitive Landscape
Product Code: ETC4610911 | Publication Date: Jul 2023 | Updated Date: Dec 2024 | Product Type: Report | |
Publisher: 6Wresearch | No. of Pages: 200 | No. of Figures: 90 | No. of Tables: 300 | |
Europe HLA Typing for Transplant Market report thoroughly covers the market by countries, technology, Product & Service, application, End -User. The market outlook report provides an unbiased and detailed analysis of the ongoing market trends, opportunities/high growth areas, and market drivers which would help the stakeholders to devise and align their market strategies according to the current and future market dynamics.
Europe HLA Typing for Transplant Market is likely to grow due to in the forecast period as The Human Leukocyte Antigen (HLA) system is a crucial factor for successful transplantation as it determines the immunological compatibility between the donor and the recipient. HLA typing plays a key role in identifying a matching donor for a transplant patient to minimize the risk of transplant rejection. The Europe HLA typing for transplant market is anticipated to witness a substantial growth rate with the advancements in technology and increasing demand for organ transplant procedures.
According to 6Wresearch, the Europe HLA Typing for Transplant Market size is projected to grow at the CAGR of 7.8 % during the forecast period of 2025-2031. One of the significant drivers of the Europe HLA typing for transplant market is the growing demand for organ and bone marrow transplants. The European Union has a population of over 500 million people, and there is always a need for transplant organs and tissues. Also, advancements in genetic testing techniques and technologies have made the HLA typing process quicker, more accurate, and more affordable. With these advancements, the overall transplant procedure has become less risky, and more lives are being saved thanks to accurate matches between donors and recipients.
The mounting demand for organ transplants and the global shortage of organs are increasing the need to perform HLA typing for transplants. Major players are taking initiatives to spread awareness about transplantation, such as promoting events and growing public relations related to transplantation. Improvements in healthcare infrastructure and innovative technological advancements are also generating Europe HLA Typing for Transplant Growth. One of the most significant challenges is the requirement of high-end infrastructure for HLA typing, which is often not available in less developed countries. Moreover, lack of awareness about transplantation and inability to perform the surgery is another significant challenge. Limited compatible donors also act as challenges. Many countries with high demand and shortage of donors attempt to procure organs illegally, which affects the growth of the HLA typing for transplant market.
Governments in Europe are also taking initiatives to promote organ donations and transplant procedures. The European Commission's action plan on organ donation and transplantation aims to improve the donation and transplantation rates in Europe through coordination, cooperation, and standardization among the member states. Moreover, initiatives such as the European Alliance for Organ Donation and Transplantation and the European Organ Donation Day are also promoting organ donation by raising awareness among the public.
The key players in the Europe HLA Typing for Transplant Industry include Thermo Fisher Scientific, Bio-Rad Laboratories, Inc., Illumina, Inc., Takara Bio Inc., and Becton, Dickinson and Company. These players are continuously investing in research and development activities to improve the HLA typing techniques. Additionally, the market is witnessing partnerships and collaborations between the key players to expand their customer base.
According to Ravi Bhandari, Research Head, 6Wresearch, Germany, the United Kingdom, France, Italy, Russia, Spain, and the rest of Europe are expected to drive the growth of the HLA typing for transplant market. Germany is projected to achieve the highest market share, followed by the United Kingdom and France. Among these countries, Germany is expected to have a significant growth rate due to an increase in transplant procedures in the country.
Molecular assay technologies and non-molecular assay technologies are the two primary segments in the Europe HLA typing for transplant market. The molecular assay technologies segment is expected to grow at a faster pace than the non-molecular technologies segment, owing to its high accuracy in detecting HLA alleles. Furthermore, technological advancements such as NGS (Next Generation Sequencing) are expected to drive the growth of the molecular assay technologies section in the coming years.
Reagents & consumables, instruments, and software & services are the primary sub-segments of the product & service segment of the Europe HLA typing for transplant market. Among these, the reagents and consumables sub-segment is expected give rise to Europe HLA Typing for Transplant Market Share due to the frequent purchase of low-cost consumables such as PCR primers, probes, and PCR beads.
The report offers a comprehensive study of the subsequent market segments:
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Europe HLA Typing for Transplant Market Overview |
3.1 Europe Regional Macro Economic Indicators |
3.2 Europe HLA Typing for Transplant Market Revenues & Volume, 2021 & 2031F |
3.3 Europe HLA Typing for Transplant Market - Industry Life Cycle |
3.4 Europe HLA Typing for Transplant Market - Porter's Five Forces |
3.5 Europe HLA Typing for Transplant Market Revenues & Volume Share, By Countries, 2021 & 2031F |
3.6 Europe HLA Typing for Transplant Market Revenues & Volume Share, By Technology, 2021 & 2031F |
3.7 Europe HLA Typing for Transplant Market Revenues & Volume Share, By Product & Service, 2021 & 2031F |
3.8 Europe HLA Typing for Transplant Market Revenues & Volume Share, By Application, 2021 & 2031F |
3.9 Europe HLA Typing for Transplant Market Revenues & Volume Share, By End-User, 2021 & 2031F |
4 Europe HLA Typing for Transplant Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.3 Market Restraints |
5 Europe HLA Typing for Transplant Market Trends |
6 Europe HLA Typing for Transplant Market, 2021 - 2031 |
6.1 Europe HLA Typing for Transplant Market, Revenues & Volume, By Technology, 2021 - 2031 |
6.2 Europe HLA Typing for Transplant Market, Revenues & Volume, By Product & Service, 2021 - 2031 |
6.3 Europe HLA Typing for Transplant Market, Revenues & Volume, By Application, 2021 - 2031 |
6.4 Europe HLA Typing for Transplant Market, Revenues & Volume, By End-User, 2021 - 2031 |
7 Germany HLA Typing for Transplant Market, 2021 - 2031 |
7.1 Germany HLA Typing for Transplant Market, Revenues & Volume, By Technology, 2021 - 2031 |
7.2 Germany HLA Typing for Transplant Market, Revenues & Volume, By Product & Service, 2021 - 2031 |
7.3 Germany HLA Typing for Transplant Market, Revenues & Volume, By Application, 2021 - 2031 |
7.4 Germany HLA Typing for Transplant Market, Revenues & Volume, By End-User, 2021 - 2031 |
8 United Kingdom HLA Typing for Transplant Market, 2021 - 2031 |
8.1 United Kingdom HLA Typing for Transplant Market, Revenues & Volume, By Technology, 2021 - 2031 |
8.2 United Kingdom HLA Typing for Transplant Market, Revenues & Volume, By Product & Service, 2021 - 2031 |
8.3 United Kingdom HLA Typing for Transplant Market, Revenues & Volume, By Application, 2021 - 2031 |
8.4 United Kingdom HLA Typing for Transplant Market, Revenues & Volume, By End-User, 2021 - 2031 |
9 France HLA Typing for Transplant Market, 2021 - 2031 |
9.1 France HLA Typing for Transplant Market, Revenues & Volume, By Technology, 2021 - 2031 |
9.2 France HLA Typing for Transplant Market, Revenues & Volume, By Product & Service, 2021 - 2031 |
9.3 France HLA Typing for Transplant Market, Revenues & Volume, By Application, 2021 - 2031 |
9.4 France HLA Typing for Transplant Market, Revenues & Volume, By End-User, 2021 - 2031 |
10 Italy HLA Typing for Transplant Market, 2021 - 2031 |
10.1 Italy HLA Typing for Transplant Market, Revenues & Volume, By Technology, 2021 - 2031 |
10.2 Italy HLA Typing for Transplant Market, Revenues & Volume, By Product & Service, 2021 - 2031 |
10.3 Italy HLA Typing for Transplant Market, Revenues & Volume, By Application, 2021 - 2031 |
10.4 Italy HLA Typing for Transplant Market, Revenues & Volume, By End-User, 2021 - 2031 |
11 Russia HLA Typing for Transplant Market, 2021 - 2031 |
11.1 Russia HLA Typing for Transplant Market, Revenues & Volume, By Technology, 2021 - 2031 |
11.2 Russia HLA Typing for Transplant Market, Revenues & Volume, By Product & Service, 2021 - 2031 |
11.3 Russia HLA Typing for Transplant Market, Revenues & Volume, By Application, 2021 - 2031 |
11.4 Russia HLA Typing for Transplant Market, Revenues & Volume, By End-User, 2021 - 2031 |
12 Spain HLA Typing for Transplant Market, 2021 - 2031 |
12.1 Spain HLA Typing for Transplant Market, Revenues & Volume, By Technology, 2021 - 2031 |
12.2 Spain HLA Typing for Transplant Market, Revenues & Volume, By Product & Service, 2021 - 2031 |
12.3 Spain HLA Typing for Transplant Market, Revenues & Volume, By Application, 2021 - 2031 |
12.4 Spain HLA Typing for Transplant Market, Revenues & Volume, By End-User, 2021 - 2031 |
13 Rest of Europe HLA Typing for Transplant Market, 2021 - 2031 |
13.1 Rest of Europe HLA Typing for Transplant Market, Revenues & Volume, By Technology, 2021 - 2031 |
13.2 Rest of Europe HLA Typing for Transplant Market, Revenues & Volume, By Product & Service, 2021 - 2031 |
13.3 Rest of Europe HLA Typing for Transplant Market, Revenues & Volume, By Application, 2021 - 2031 |
13.4 Rest of Europe HLA Typing for Transplant Market, Revenues & Volume, By End-User, 2021 - 2031 |
14 Europe HLA Typing for Transplant Market Key Performance Indicators |
15 Europe HLA Typing for Transplant Market - Opportunity Assessment |
15.1 Europe HLA Typing for Transplant Market Opportunity Assessment, By Countries, 2021 & 2031F |
15.2 Europe HLA Typing for Transplant Market Opportunity Assessment, By Technology, 2021 & 2031F |
15.3 Europe HLA Typing for Transplant Market Opportunity Assessment, By Product & Service, 2021 & 2031F |
15.4 Europe HLA Typing for Transplant Market Opportunity Assessment, By Application, 2021 & 2031F |
15.5 Europe HLA Typing for Transplant Market Opportunity Assessment, By End-User, 2021 & 2031F |
16 Europe HLA Typing for Transplant Market - Competitive Landscape |
16.1 Europe HLA Typing for Transplant Market Revenue Share, By Companies, 2024 |
16.2 Europe HLA Typing for Transplant Market Competitive Benchmarking, By Operating and Technical Parameters |
17 Company Profiles |
18 Recommendations |
19 Disclaimer |